Back to search results

Pediatric PET/MR Image Registry for Tumor Diagnosis

This study is comparing different imaging methods to see which ones work best for diagnosing tumors in children and young adults up to age 40. The imaging methods being compared are whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and PET/Computed Tomography (CT) imaging. Researchers want to see how well each method finds tumors (sensitivity), how accurately they identify tumors when they are present (specificity), and their overall diagnostic accuracy. You may be able to join if you have a confirmed solid tumor or a new mass that doctors strongly suspect is a solid tumor. Some patients with leukemia might also be included if there's concern about a focal lesion. The study aims to measure the number of tumors found over a period of up to 12 months. The current recruitment status is unclear.

Study design
This is an observational study with a planned enrollment of 100 participants. It compares different imaging techniques for diagnosing tumors.
What's involved
Participants will undergo PET/MR imaging, MR imaging, and/or PET/CT imaging. The study measures the number of tumors found for up to 12 months.
Compensation
Not stated in the trial record.
Follow-up
The study measures the number of tumors for up to 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03458520

Pediatric PET/MR Image Registry

Recruiting
Not specifiedUp to 40Observational
Stanford University
~100 participants
Updated 2026-02-09 on ClinicalTrials.gov
What's tested:PET/MR imagingMR imagingPET/CT imaging

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of tumors
Measured over up to 12 months

Conditions

Soft Tissue
Lymphoma
Osteosarcoma

Explore related trials

LeukemiaLymphomaOsteosarcomaSoft Tissue SarcomaSolid Neoplasm

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Heike Daldrup-Link, MD · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

Anne Muehe
[email protected]
650-720-8601
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor.
We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs.
Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.

Exclusion

Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level \> 200 mg/dl.
Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age).
Patient has a CNS primary tumor.
Pregnant women and fetuses

What this trial measures

  • Number of tumorsup to 12 months

    Number of tumors detected on whole body MRI, PET/MR and (if available) PET/CT scans.